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2Abstract
The purine adenosine plays an important role in a number of physiological and
pathological processes and is neuroprotective during hypoxia and ischemia. The
major effect of adenosine is to suppress network activity via the activation of A1
receptors. Here we report that in immature cerebellar slices, the activation of A1
receptors has variable effects on parallel fibre synaptic transmission, ranging from
zero depression to an almost complete abolition of transmission. Concentration-
response curves suggest that the heterogeneity of inhibition stems from differences in
A1 receptor properties which could include coupling to downstream effectors. There
is less variation in the effects of adenosine at parallel fibre synapses in slices from
older rats and thus adenosine signalling appears developmentally regulated.
In the cerebellum, hypoxia increases the concentration of extracellular
adenosine leading to the activation of A1 receptors (at adenosine-sensitive parallel
fibre synapses) and the suppression of glutamate release. It would be predicted that
the synapses that were insensitive to adenosine would be less depressed by hypoxia
and thus maintain function during metabolic stress. However those synapses which
were insensitive to adenosine were rapidly inhibited by hypoxia via a mechanism
which was not reversed by blocking A1 receptors. Thus another mechanism must be
responsible for the hypoxia-mediated depression at these synapses. These different
mechanisms of depression maybe important for cell survival and for maintenance of
cerebellar function following oxygen starvation.
31. Introduction
Adenosine plays important roles in a number of physiological and pathological
processes in the brain (for review see Dunwiddie and Masino, 2001; Dale and
Frenguelli, 2009). Adenosine accumulates during hypoxia and ischemia and has a
neuroprotective role (Goldberg et al. 1988; Von Lubitz et al 1988; Cunha 2005)
reducing the brains energy requirements during periods of metabolic stress. The
actions of adenosine are well characterised, it acts via multiple cell surface G-protein
coupled receptors: A1, A2A, A2B and A3 (Fredholm et al. 2000). The major effect of
adenosine is to dampen down network excitation via A1 receptor activation.
Adenosine A1 receptors inhibit Ca2+ influx via voltage gated Ca2+ channels leading to
reduced transmitter release (Gundlfinger et al. 2007) and A1 receptors activate
inwardly rectifying K+ channels (GIRKs) leading to the hyperpolarisation of the
membrane potential (Lüscher et al. 1997).
In many brain regions A1 receptors are present on the terminals of
glutamatergic neurones where they reduce glutamate release. In the cerebellum, A1
receptors are present on both parallel fibre (Kocsis et al. 1984; Takahashi et al. 1995;
Dittman and Regher, 1996; Wall et al. 2007) and climbing fibre terminals (Takahashi
et al. 1995) where they reduce the release of glutamate. In a previous study, we
discovered that a proportion of parallel fibre synapses in immature cerebellar slices
were either weakly modulated by adenosine or not affected at all (Atterbury and Wall,
2009). Here we have investigated these synapses in more detail and found that other
than the difference in modulation by adenosine, these synapses appear functionally
identical to synapses which are strongly modulated by adenosine. We suggest that the
difference in modulation stems from variation in adenosine receptor properties or
4coupling to effectors rather than differences in adenosine metabolism or uptake.
These synapses are still depressed during hypoxia although the mechanism does
not appear to involve the activation of A1 receptors by the increased extracellular
adenosine concentration.
2. Methods
2.1 Preparation of cerebellar slices
Transverse slices of cerebellar vermis (400 µm) were prepared from male Wistar rats,
at postnatal days 9-28 (P9-28). As described previously (Wall et al. 2007) and in
accordance with the U.K. Animals (Scientific Procedures) Act (1986), male rats were
killed by cervical dislocation and then decapitated. The cerebellum was rapidly
removed and slices were cut on a Microm HM 650V microslicer in cold (2-4ºC) high
Mg2+, low Ca2+ aCSF, composed of (mM): 127 NaCl, 1.9 KCl, 7-8 MgCl2, 0.5 CaCl2,
1.2 KH2PO4, 26 NaHCO3, 10 D-glucose (pH 7.4 when bubbled with 95% O2 and 5%
CO2, 300 mOSM). Slices were stored in normal aCSF (1.3 mM MgCl2, 2.4 mM
CaCl2) at room temperature for 1-6 hours before recording.
2.2 Extracellular recording
An individual slice was transferred to a recording chamber, submerged in normal
aCSF and perfused at 6 ml/min (30-32C). The slice was placed upon a suspended
grid to allow perfusion of the slice from above and below and thus reduce the
likelihood of hypoxia. Furthermore, all solutions were vigorously bubbled (95% O2/
5% CO2) and all tubing had low gas permeability (Tygon, Fisher). For the stimulation
5of parallel fibres, square voltage pulses (2- 5V, 200 s duration) were delivered by an
isolated pulse stimulator (model 2100 AM systems Everett WA USA) via a concentric
bipolar metal stimulating electrode (FHC, Bowdoin, ME, USA) placed on the surface
of the molecular layer. The recording electrode (an aCSF filled microelectrode) was
placed on the same track along which the parallel fibres travel (“on-beam”, Yuan and
Atchison, 1999). A typical extracellular field potential consisted of an initial
component which persisted in 5 mM kynurenate but was blocked by 1 M TTX
(parallel fibre volley) followed by a component which could be blocked by 1 M
TTX and greatly reduced by 5 mM kynurenate. This component (fEPSP) probably
consists of parallel fibre-mediated glutamatergic excitatory synaptic potentials which
maybe combined with action potentials in Purkinje cells and interneurones (Clark and
Barbour, 1997). Parallel fibre fEPSP amplitude was estimated from the kynurenate-
sensitive potential, which was measured by subtracting the potential that remained in
kynurenate from control potentials. Confirmation of PF fEPSP identity was achieved
by evoking pairs of fEPSPs (interval 50 ms) and observing facilitation (20-30%) and
by examining the pharmacological profile (inhibition by mGlu4 receptor agonists and
by glutamate receptor antagonists). The firing rate of Purkinje cells was measured
using an aCSF filled patch pipette placed in the Purkinje cell layer. Recordings that
were obviously from multiple units (different spike amplitudes) were discarded.
Extracellular recordings were made using an ISO-DAM extracellular amplifier (WPI,
Stevenage UK), filtered at 1 kHz and digitised on line (10 kHz) with a Micro CED
(Mark 2, Cambridge UK) interface controlled by Spike (Vs 6.1).
62.3 Drugs
All drugs were made up as 10-100 mM stock solutions, stored frozen and then thawed
and diluted with aCSF on the day of use. Adenosine, baclofen, N-
cyclopentyladenosine (CPA), tetrodotoxin (TTX) and 8-cyclopentyltheophylline
(8CPT) were purchased from Sigma (Poole, UK). Kynurenic acid, CNQX (6-cyano-7-
nitroquinoxaline-2,3-dione) and L-AP4 (L-(+)-2-Amino-4-phosphonobutyric acid)
were purchased from Ascent Scientific (Bristol, UK).
2.4 Statistics
All quoted data is mean ± SEM. For statistical analysis, paired and unpaired student’s
t tests were performed. Data was described with either sigmoid curves or linear fits
using Origin 8.5 (Silverdale Scientific Ltd, Stoke Mandeville UK)
3. Results
3.1 Adenosine has heterogeneous effects on synaptic transmission at immature
parallel fibre synapses.
In a previous study (Wall and Atterbury, 2009) we reported that at a proportion of
parallel fibre synapses in cerebellar slices from immature rats (postnatal days 9-12),
adenosine had little effect on synaptic transmission. In that study such synapses were
not analysed further. Here we investigate the modulation of parallel fibre synapses by
adenosine in more detail. In 167 slices, the mean reduction in PF-fEPSP (parallel
fibre field excitatory postsynaptic potential) amplitude produced by the application of
7100 M adenosine was 48 ± 2 %, which was accompanied by a significant (P<0.01)
increase in paired pulse facilitation (interval 50 ms) from 1.38 ± 0.02 to 1.67 ± 0.07.
There was considerable variation (Fig. 1B) in the reduction of fEPSP amplitude
produced by adenosine (co-efficient of variance 0.68) ranging from no effect in 21
slices (Fig. 1A, B), to an almost complete abolition of transmission in 3 slices (> 90 %
reduction in fEPSP amplitude). The reduction in fEPSP amplitude strongly correlated
with the increase in paired pulse ratio (r = 0.7, Fig. 1C) suggesting that the inhibition
was presynaptic (Dunwiddie and Haas, 1985).
We investigated whether the degree of adenosine-mediated inhibition
correlated with any synaptic properties. In all slices, synaptic transmission showed
paired pulse facilitation before adenosine application (50 ms interval, paired pulse
ratio 1.38 ± 0.02) and fEPSP amplitude could be greatly reduced (> 80 % reduction)
following block of glutamate receptors with either 5 mM kynurenic acid or 10 M
CNQX. There was no correlation: between the reduction in fEPSP amplitude (100 M
adenosine) and the initial (before adenosine application) fEPSP amplitude (r = 0.03,
not illustrated), between the initial amount of paired pulse facilitation (before
adenosine application) and reduction in fEPSP amplitude (r = 0.04, Fig. 1D) and
between the magnitude of adenosine inhibition and the age of rat from which the
cerebellar slices were made (P8-14, r = 0.04, not illustrated). Dunwiddie (1985)
showed that the amount of inhibition produced by adenosine (on hippocampal fEPSPs)
was reduced with larger stimulation voltages, although the effects of adenosine on
paired pulse facilitation were independent of stimulation strength (Dunwiddie and
Haas, 1985). In our experiments, the smallest stimulation voltage was used in order to
produce a measurable fEPSP and thus the stimulation voltage was relatively constant
across experiments. Also the effects of adenosine on fEPSP amplitude correlates with
8the effects on the paired pulse ratio (Fig. 1C). Metabotropic glutamate receptors of the
mGlu4 subtype are only expressed by parallel fibres in the cerebellum (Mateos et al.
1998) and thus inhibition of fEPSPs by their activation with the agonist L-AP4
confirms that parallel fibre synapses are activated. In all slices tested, L-AP4 (50 M)
significantly reduced fEPSP amplitude (mean inhibition 58 ± 2, n = 40 slices),
whether or not adenosine had any effect on fEPSP amplitude. There was no
correlation between the reduction in fEPSP amplitude produced by L-AP4 and the
inhibition produced by 100 M adenosine (Fig. 1A, E). Parallel fibres also express
GABAB receptors, which inhibit transmitter release (Batchelor and Garthwaite, 1992;
Wall and Dale, 2007). In 9 slices, where adenosine (100 M) produced little or no
inhibition (< 20 % reduction in fEPSP amplitude), activation of GABAB receptors
with 10-25 M baclofen produced an almost complete abolition of synaptic
transmission (mean reduction in amplitude 97 ± 3 %, Fig. 1A). Thus synapses which
were either weakly modulated or unaffected by adenosine were still strongly inhibited
by either GABAB receptor or mGlu4 receptor activation.
3.2 There is less variation in adenosine inhibition in slices from older rats
To investigate if the adenosine-insensitivity of parallel fibre synapses persists
during cerebellar development, recordings were made from parallel fibre
synapses in slices from older rats (average age 23 ± 0.2 postnatal days). The
average inhibition produced by 100 M adenosine was 59 ± 2 %, with the paired
pulse ratio increased from 1.5 ± 0.02 to 2 ± 0.08 (n =59 slices and see Wall et al.
2007). Although the degree of inhibition was variable, ranging from 27 to 100 %
(CV 0.29), in a sample of 59 slices no synapses were completely insensitive to
9adenosine (Fig. 2A). As with immature synapses there was no relationship
between the degree of inhibition with fEPSP amplitude (r = 0.002) or initial
paired pulse ratio (r = 0.04). In 14 slices, the inhibition produced by 100 M
adenosine was compared to that produced by 50 M L-AP4 (mean inhibition 62
± 4 %) and there was only a weak relationship (r = 0.14, Fig. 2B). Thus although
there is still variation in the effects of adenosine across synapses in older animals,
it appears less than at immature synapses.
3.3 Neither adenosine nor L-AP4 modulate Purkinje cell firing rate
It has been suggested that the field response evoked by parallel fibre stimulation
consists of a combination of EPSPs and action potentials in Purkinje cells,
interneurones and Bergmann glia (Clark and Barbour, 1997). If the field response is
contaminated with population spikes this could explain the variation in effects
between baclofen, L-AP4 and adenosine. If baclofen and L-AP4 have some
postsynaptic effect (moving the cell away from threshold) resulting in a loss of
population spikes this could explain their greater efficacy and consistent depressant
action on synaptic transmission. This seems unlikely as mGlu4 receptors only appear
to be expressed on parallel fibres (and not on postsynaptic cells, Mateos et al. 1998)
and the stimulation strengths are low and are unlikely to activate enough parallel
fibres to fire a Purkinje cell. However to exclude this possibility, the firing rate of
spontaneously active Purkinje cells was measured in control and following the
application of adenosine (100 ), L-AP4 (50 M) and baclofen (25 M). Neither
adenosine nor L-AP4 had any effect on the firing rate of Purkinje cells (control
10
instantaneous firing rate, 13.0 ± 1.6 Hz, adenosine 13.1 ± 1.6, L-AP4 13.5 ± 1.6)
although baclofen (7.6 ± 1.6 Hz) significantly (P<0.01) reduced the firing rate (Fig. 3).
Thus the more consistent effect of L-AP4 on synaptic transmission compared to
adenosine does not appear to stem from a postsynaptic action.
3.4 The effects of adenosine are blocked by the A1 receptor antagonist 8CPT
We have investigated whether the effects of adenosine are only through the activation
of A1 receptors. Recent evidence suggests that A2A receptors (Brooks et al. 2008)
may be expressed in the cerebellum and as they can facilitate synaptic transmission
(Quarta et al. 2004) the variation in synaptic inhibition block could stem from the
combined activation of inhibitory A1 receptors and facilitatory A2A receptors.
However in 20 slices, we found that applying adenosine in the presence of the
selective A1 receptor antagonist 8CPT (1-2 ) had no effect (data not shown), even
if adenosine had little effect on fEPSP amplitude in control. Thus the lack of effect on
fEPSP amplitude cannot be explained by activation of multiple receptor subtypes with
opposing effects.
3.5 Concentration responses at synapses sensitive and insensitive to adenosine
inhibition
Usually 100 M adenosine would activate the majority of synaptic A1 receptors and
thus be close to the top of the concentration-response curve (Takahashi et al. 1995;
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Kimura et al. 2003). However, at synapses were 100 M adenosine had little effect on
fEPSP amplitude, the concentration-response curve may be shifted to the right. Thus
the effects of applying higher concentrations (300 M) of adenosine were investigated.
Slices could be divided into 2 groups: in the first group 300  adenosine produced
little or no extra inhibition compared to 100 M adenosine (n = 8, 54 ± 8 % Vs 50 ±
11 % inhibition, Fig. 4A) with effects comparable to L-AP4 (50 M). In the second
group, 300 M adenosine had a much larger effect on fEPSP amplitude than 100 M
adenosine (12 ± 3.1 Vs 36 ± 9 %, n = 8, Fig. 4B). This large increase in inhibition
produced by 300 M adenosine (~ 3 times that produced by 100 M) suggests that at
these synapses 100 M adenosine is not at the top of the concentration-response curve.
This could be the result of rapid extracellular adenosine breakdown so that the
concentration of adenosine reaching the receptors is low or perhaps at some synapses
there is expression of low potency receptors. To test for changes in receptor properties,
concentration-response curves were constructed for the non-hydrolysable A1 receptor
agonist CPA. Adenosine (100 M) was first applied to identify synapses where there
was either little or no inhibition (n = 6, mean reduction in fEPSP amplitude 15.8 ±
5 %) or synapses where adenosine produced at least a 50 % reduction in fEPSP
amplitude (mean inhibition 68 ± 5 %, n = 7). The identity of all synapses was
confirmed by applying L-AP4 (50 M) which markedly reduced fEPSP amplitude (<
50 % inhibition). Concentration response curves were then constructed by
sequentially adding increasing concentrations of CPA (0.001 µM to 100 µM). At
synapses were adenosine produced a marked reduction in fEPSP amplitude, CPA
almost completely inhibited synaptic transmission (90 ± 4.4 % block, Fig. 4C, E, F)
with an IC50 of n (in agreement with previous studies, Wall and Atterbury, 2009).
The effects of CPA could only be reversed with large concentrations of 8CPT (10-20
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M). At synapses where adenosine had little or no effect on fEPSP amplitude, the
concentration response curve was shifted to the right (IC50 of 250 nM, Fig 3D, E) with
a maximal inhibition (% inhibition of fEPSP amplitude with 100 M CPA, 53 ±
0.6 %, Fig. 4F). The effects of CPA were readily reversed by 8CPT (2 M)
suggesting that the affinity of the receptor for CPA was reduced. Thus synapses show
variation in the potency of CPA suggesting that the variation stems from receptor
properties (and possibly downstream signalling) rather than differences in adenosine
uptake and metabolism.
3.6 Changes in the presynaptic volley can account for adenosine inhibition at
insensitive synapses
Adenosine has a small effect on the presynaptic volley, reducing it by ~ 10 %
(Dunwiddie and Miller, 1993; Dittman and Regher, 1996; Wall et al. 2008). We have
investigated whether this reduction in volley amplitude is sufficient to account for the
reduction in fEPSP amplitude at synapses sensitive and relatively insensitive to
adenosine inhibition. For each slice we varied the stimulus strength and then
constructed a plot of volley amplitude against fEPSP amplitude. We then applied
adenosine (100 M) and L-AP4 (50 M) to inhibit transmission. If the reduction in
volley amplitude (produced by adenosine and L-AP4) can account for the reduction in
fEPSP amplitude then, when plotted, the point will fall upon the volley Vs fEPSP
amplitude curve. If the reduction in volley amplitude is too small to account for the
reduction in fEPSP amplitude, then the point will fall below the line. We confirmed
the identity of the volley: it persists following application of the glutamate receptor
antagonist kynurenate (5 mM) and is blocked by TTX (0.5 M, n = 5). In the
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majority of slices (9 out of 12), the reduction in volley amplitude (produced by either
adenosine or L-AP4) was much too small to account for the reduction in fEPSP
amplitude and the points were well below the line (Fig. 5A, B, C also reported in
hippocampus Dunwiddie, 1984). However, in 3 out of 12 slices where the effect of
adenosine on fEPSP amplitude was small (~10-15 %) the reduction in fEPSP
amplitude could be accounted for by the change in volley amplitude (with the point
falling on the curve, Fig 5C, D, E). This suggests that the mechanisms of synaptic
inhibition may differ between sensitive and insensitive synapses.
3.7 Effects of hypoxia on synapses sensitive and insensitive to adenosine
Starvation of O2 (hypoxia) produces a marked increase in extracellular adenosine
concentration in brain tissue, activating presynaptic A1 receptors leading to the
inhibition of transmitter release (Fowler, 1990; Winn et al. 1981; Katchman and
Hershkowitz, 1993; Frenguelli et al. 2003). It has been reported that hypoxia-
mediated adenosine release in the cerebellum depresses parallel fibre synaptic
transmission, an effect reversed by blocking A1 receptors (Atterbury and Wall, 2009).
However these experiments were performed in slices where adenosine (100 M)
produced a large inhibition of transmission (< 50 % reduction in PF fEPSP amplitude).
We have investigated if parallel fibre synapses, where adenosine has little effect on
synaptic transmission, are either resistant or show a smaller response to hypoxia.
In confirmation of previous data (Atterbury and Wall, 2009), at synapses
where adenosine (100 M) had a large effect on fEPSP amplitude (mean inhibition 68
± 4 %, n = 6 slices) hypoxia (aCSF bubbled with N2/CO2) induced a slow depression
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of transmission (steady state reduction in fEPSP amplitude 43 ± 3 %, delay to onset of
inhibition 161 ± 37 s, time from start of depression to maximum inhibition 327 ± 34 s,
Fig. 6A). This inhibition was accompanied by a significant (P<0.01) increase in
paired pulse ratio (from 1.29 ± 0.05 to 1.7 ± 0.07, Fig. 6B) but there was no
significant change in the amplitude of the presynaptic volley (0.47 ± 0.07 Vs 0.47 ±
0.06 mV). Thus there is a reduction in transmitter release with no change in the
number of active parallel fibres. The effects of hypoxia were almost completely
reversed (85 ± 3 %) by blocking A1 receptors with 8-CPT (2 M, Fig. 6A). Thus in
these slices, the major short-term effect of hypoxia is to activate presynaptic A1
receptors leading to reduced parallel fibre glutamate release.
In slices where 100 M adenosine had a significantly (P<0.001) smaller effect
on fEPSP amplitude (mean inhibition 19 ± 3 % Vs ~68 %, n = 5), hypoxia still
induced depression (mean inhibition of fEPSP amplitude 62 ± 5 %, Fig. 6C). This
inhibition was significantly (P<0.01) larger than observed with synapses that were
sensitive to adenosine and it was quicker to occur (delay 70.6 ± 6.2 vs 161 ± 37 s and
time from start of depression to maximum inhibition 75 ± 44 Vs 327 ± 34 s, Fig. 6C).
In 3 out of 5 slices the inhibition was accompanied by a large increase in the paired
pulse ratio (Fig. 5D), in the other slices there was little change in the ratio (overall
change in paired pulse ratio from 1.34 ± 0.06 to 1.78 ± 0.17). There was no significant
(P = 0.4) change in the amplitude of the presynaptic volley during hypoxia (0.37 ± 0.1
Vs 0.44 ± 0.13 mV) and hence no change in the number of active parallel fibres. The
inhibition produced by hypoxia was not reversed by 8 CPT (transient increase in
fEPSP amplitude 21 ± 6 %, Fig. 6C) and thus most of the inhibition was not produced
by extracellular adenosine acting via A1 receptors. As activation of either mGlu4 or
GABAB receptors will inhibit parallel fibre transmitter release, mGlu4 and
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GABAB receptor antagonists were applied (in the presence of 8CPT) to
investigate whether they could reverse the effects of hypoxia. Neither MSOP (100
M, mGlu4R antagonist, n = 3) or CGP5248 (20 M, GABAB receptor
antagonist, n = 4) had any effect on fEPSP amplitude. The reduction in fEPSP
amplitude was almost completely removed by washing back in oxygenated aCSF.
4. Discussion
We have found considerable variation in the reduction of fEPSP amplitude produced
by the application of adenosine to parallel fibre synapses in slices from immature rats
(confirming previous results Atterbury and Wall, 2009). Differences in adenosine-
sensitivity were observed in slices from the same rat and in recordings from different
molecular layers in the same slice. Future experiments will investigate whether
these insensitive and sensitive synapses occur in specific cerebellar lobes. The
observation that activation of other presynaptic receptors present on parallel fibre
terminals (mGluR4 and GABAB) produces consistent amounts of inhibition shows
that the variation is specific to adenosine signalling. Furthermore, the consistent
inhibitory effects of L-AP4 confirm that all the fEPSPs recorded result from parallel
fibre stimulation (Mateos et al. 1998).
Since recordings of parallel fibre fEPSPs were made using an extracellular
electrode, the precise composition of the population of postsynaptic cells recorded
from is not known. The major postsynaptic cell type in the molecular layer is the
Purkinje cell (1000s of parallel fibres make synapses onto Purkinje cell dendrites) but
field recordings will also potentially include EPSPs from molecular layer
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interneurones (Liu and Cull-Candy, 2000) and from Bergmann glia (Clark and
Barbour, 1997; Bellamy and Ogden, 2005; Bellamy, 2007). One hypothesis for the
variation in adenosine inhibition is that parallel fibres synapses onto different
postsynaptic cell types have different sensitivities to adenosine and that the variation
in fEPSP inhibition stems from differences in the proportion of sensitive and
insensitive synapses recorded from. The evidence for such a hypothesis is relatively
weak. Parallel fibre synapses onto Purkinje cells are modulated by adenosine (IC50 1.1
M, maximum block ~80 %, 100 M adenosine close to the top of the concentration
response curve, Takahashi et al. 1995). There is currently no data for the effects of
CPA (non-hydrolysable and non-transported A1 receptor agonist) on parallel fibre to
Purkinje cell synapses using whole cell patch clamp recording. Synaptic transmission
between parallel fibres and Bergmann glia is also modulated by the activation of A1
receptors (CPA has an EC50 of 490 nM and produces a maximal inhibition of ~71 %,
Bellamy, 2007). The sensitivity of parallel fibre-molecular layer interneuron synapses
to adenosine (and CPA) inhibition is currently not known. We found that synapses
that were sensitive to adenosine had an EC50 for CPA of ~ 50 nM and a maximal
inhibition of 100%. It is possible to hypothesise that fEPSPs recorded from an almost
pure population of parallel fibre-Purkinje cell synapses are sensitive to adenosine
(most synapses) whereas fEPSPs arising from either mixtures of postsynaptic cell
types or from relatively pure populations of Bergmann glia/ interneurones are less
sensitive to adenosine. Conversely, it is also possible that different parallel fibre
synapses onto Purkinje cells have different sensitivities to adenosine.
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4.1 What determines the degree of inhibition produced by adenosine?
Application of 100 M adenosine produced different amounts of inhibition at
different parallel fibre synapses. This variation could be the result of different
amounts of adenosine reaching the synaptic receptors due to differences in adenosine
metabolism and uptake. The reported Kd value for adenosine at A1 receptors is ~600-
700 nM (hippocampus, Dunwiddie and Diao, 1994) and thus 100 M adenosine
should saturate the receptors and produce a maximal effect. However adenosine is
rapidly removed from the extracellular space (by uptake and by metabolism) and thus
only a small fraction of exogenous adenosine actually reaches the receptors.
Although differences in the metabolism and uptake of adenosine would explain the
variation this is not supported by the experiments using the non-hydrolysable
adenosine analogue CPA (which is also not transported) which suggest that the
differences in sensitivity lies at the level of the A1 receptor. The rightward shift in the
concentration-response curve and reduction in maximal inhibition shows that the
potency of CPA at the receptor is reduced. This could reflect differences in both
receptor affinity and efficacy. Changes in the number of receptors expressed at the
synapse could explain the drop in maximal response but would not explain the
rightward shift in concentration-response curve. Adenosine A1 receptors show very
slow desensitisation and internalisation (reviewed by Palmer and Stiles, 1997) and
this coupled with the low adenosine tone measured in slices (Atterbury and Wall,
2009) suggests that that receptor desensitisation/internalisation is unlikely to explain
the difference between synapses. It is possible that the efficacy of downstream
signalling from the receptor to the Ca2+ channels/release machinery or K+ channels is
reduced. The A1 receptor subtype couples to both Gi- and Go-proteins in different
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systems, enabling a number of transduction mechanisms to inhibit synaptic
transmission. Differences in the complement of presynaptic voltage-gated Ca2+
channels involved in transmitter release between individual parallel fibres could
underlie the variation in inhibition, if A1 receptors only inhibit certain Ca2+
channel subtypes. It has been reported that there are multiple subtypes of Ca2+
channel involved in parallel fibre transmitter release (N, P and Q Doroshenko et
al 1997). At most synapses the actions of adenosine cannot be accounted for by an
action on the presynaptic volley (also reported by Dundwiddie 1984). However in
synapses where the effects of adenosine on fEPSP amplitude were small, the
inhibition could be explained by changes in volley amplitude. The volley is a
compound action potential which scales with stimulus strength. Thus at these
synapses the reduction in transmitter release may simply stem from a reduction in the
number of active fibres. Adenosine can activate GIRK K+ channels which could
cause action potential failures (by hyperpolarisation) or could reduce Ca2+ influx via
voltage gated Ca2+ channels which may otherwise contribute to depolarisation.
4.2 Hypoxia
Hypoxia produces a rapid accumulation of extracellular adenosine which
activates presynaptic A1 receptors leading to membrane potential
hyperpolarisation and the inhibition of excitatory synapses (reviewed in Krnjević
2008; Frenguelli and Dale, 2009). This helps to reduce the brains energy
requirements enabling it to maintain the minimal metabolism required for
survival and is thus neuroprotective in adult brain (Krnjević 2008; Cunha 2005).
In the cerebellum, parallel fibre synapses (that were sensitive to adenosine) were
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markedly depressed by hypoxia, as a result of the increased concentration of
extracellular adenosine activating A1 receptors and reducing glutamate release
(also see Atterbury and Wall, 2009). It might be expected that synapses that
were not sensitive to inhibition by adenosine would be much more resistant to
hypoxia, equivalent to hypoxia induced in the presence of an A1 receptor
antagonist where there is only slow and partial depression (for example see
Gribkoff et al 1990). Surprisingly, these synapses were not resistant to hypoxia
but instead appeared more sensitive (a quicker onset of depression and a larger
steady state reduction in fEPSP amplitude). This inhibition was not produced by
the activation of A1 receptors, as it was not reversed by A1 receptor antagonists
(which only had a small transient action). However the reduction in EPSP
amplitude could be reversed following reoxygenation.
What is the mechanism of hypoxia-mediated depression at these synapses?
The mean increase in paired-pulse ratio suggests that some of the effects are
presynaptic (reduction in glutamate release), although the effects of hypoxia on
paired-pulse ratio were not consistent, with no effect at some synapses. There
was no change in the presynaptic volley and thus the number of active parallel
fibres was not reduced. Receptors such as mGluR4 and GABAB are present on
parallel fibre terminals and could reduce the release of glutamate if activated
(Mateos et al. 1998; Batchelor and Garthwaite, 1992). In the hippocampus,
following block of A1 receptors, part of the remaining hypoxia-induced
depression can be relieved with a group III mGluR antagonist (MPPG, de
Mendonça and Ribeiro 1997b). There is also evidence that activation of mGluR
(Groups I and III) can attenuate the action of adenosine via A1 receptors (de
Mendonça and Ribeiro 1997a). However, hypoxia-induced depression was not
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reduced by either mGlu4 or GABAB receptor antagonists and thus they do not
appear to be involved. There are a number of ion channels that can be acutely
modulated by hypoxia including Ca2+ channels and K+ channels which could
underlie the inhibition (see Krnjević 2008 for review).
Why are there multiple mechanisms of hypoxia-induced depression at
immature parallel fibre synapses? It has been suggested that, unlike adult brain,
the activation of A1 receptors maybe ineffective or even detrimental to neuronal
survival following hypoxia in the immature brain (reviewed in Cunha 2005).
Thus the neurones less-sensitive to adenosine may be preferentially protected
following a hypoxic insult and thus may play an important role in maintaining
cerebellar function. Future work is required to determine the precise anatomical
location of these neurones in the cerebellar vermis providing a clue to their
function.
4.3 Conclusions
There is variation in the inhibition of synaptic transmission at immature parallel fibre
synapses produced by A1 receptor activation. Some synapses are potently inhibited
while others appear resistant. This variation could stem from differences in receptor
expression, affinity and efficacy and maybe developmentally regulated as less
variation is apparent in slices from older rats. Hypoxia depress all synapses whether
sensitive or insensitive to adenosine but by different mechanisms and this maybe
important for maintaining cerebellar function during metabolic stress.
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Legends
Fig. 1. Heterogeneous actions of adenosine at parallel fibre synapses in cerebellar
slices from P9-12 rats. A: Graph plotting the amplitude of individual parallel fibre
fEPSPs against time. Application of 100 M adenosine had no effect on fEPSP
amplitude but baclofen (25 M, GABAB receptor agonist) and L-AP4 (50 M,
mGluR4 agonist) greatly reduced fEPSP amplitude. At the end of the experiment,
fEPSPs were blocked with 5 mM kynurenate. B: Graph illustrating the distribution of
adenosine inhibition (% reduction in fEPSP amplitude) in 167 slices (dotted line is the
mean inhibition, 47.7 %). Inset, superimposed average fEPSPs (15 fEPSPs) in control
and in 100 M adenosine recorded from 2 slices illustrating the range of inhibition
observed. C: Graph plotting the percentage increase in paired pulse ratio (produced by
100 M adenosine) against percentage reduction in fEPSP amplitude produced by 100
M adenosine. The data can be described by a linear fit (slope 0.4, R = 0.7). D: Graph
plotting initial fEPSP paired-pulse ratio against percentage reduction in fEPSP
amplitude produce by adenosine (100 M, the linear fit has an r value of 0.03). E:
Graph plotting the percentage reduction in fEPSP amplitude produced by 50 M L-
AP4 against the percentage reduction in fEPSP amplitude produced by adenosine
(100 M). The linear fit has a slope of 0.35.
Fig. 2. Actions of adenosine at parallel fibre synapse in cerebellar slices from older
rats (P21-28). A: Graph illustrating the distribution of adenosine inhibition (%
reduction in fEPSP amplitude) in 59 slices (dotted line is the mean inhibition, 59 %)
from P21-28 rats. B: Graph plotting the percentage reduction in fEPSP amplitude
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produced by 50 M L-AP4 against the percentage reduction in fEPSP amplitude
produced by adenosine (100 M). The linear fit has a slope of -0.03.
Fig. 3. Adenosine and L-AP4 do not change the firing rate of Purkinje cells recorded
in slices from P9-12 rats. A: Graph plotting the instantaneous firing rate (Hz) of a
Purkinje cell against time. Application of adenosine (100 M) or L-AP4 (50 M) had
no effect on the firing rate although addition of baclofen (25 M) significantly
reduced the firing rate. The dotted line is the mean firing rate in control (16. 4 Hz). B:
Graph summarising Purkinje cell firing rate data from 5 slices.
Fig. 4. Variation in adenosine receptors properties in slices from P9-12 rats. A: Graph
plotting the normalised amplitude of individual fEPSPs against time (fEPSPs were
normalised by dividing by mean fEPSP amplitude in control). Application of 100
followed by 300 M adenosine produced a similar percentage (~55 %) reduction of
fEPSP amplitude. Application of L-AP4 (50 M) also reduced fEPSP amplitude
confirming that EPSPs were from parallel fibre synapses. B: Graph plotting the
normalised amplitude of individual PF fEPSPs against time (fEPSPs were normalised
by dividing by mean fEPSP amplitude in control). In this slice, 300 M adenosine
produced a much larger reduction in fEPSP amplitude (~35 %) than 100 M
adenosine (15 %). Application of L-AP4 (50 M) also reduced fEPSP amplitude
confirming that fEPSPs were from parallel fibre synapses. C: Graph plotting the
amplitude of individual PF EPSPs against time for synapses sensitive to adenosine
(100 M adenosine abolished EPSPs). The amplitude of fEPSPs has been normalised
to the average fEPSP amplitude in control. Increasing concentrations of the A1
receptor agonist CPA (from 0.01 to 1 M) produced greater reduction in EPSP
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amplitude. Application of 10 M 8 CPT (in the presence of 1 M CPA) reversed the
inhibition. Inset, superimposed average fEPSPs in control (20 fEPSPs) and in the
presence of 100 M adenosine for same slice as (C). D: Graph plotting the amplitude
of individual PF fEPSPs against time for synapses relatively insensitive to adenosine
(100 M adenosine reduced EPSP amplitude by ~30 %). The amplitude of fEPSPs
has been normalised to the average fEPSP amplitude in control. Increasing
concentrations of the A1 receptor agonist CPA (from 0.01 to 10 M) produced greater
reductions in fEPSP amplitude. Application of 2 M 8 CPT (in the presence of 10 M
CPA) reversed the inhibition Inset, superimposed average fEPSPs in control (15
fEPSPs) and in the presence of 100 M adenosine. E: Log concentration-response
curves plotting percentage inhibition (relative to maxium inhibition) against log
concentration of CPA (M). The open circles were from synapses where application
of adenosine (100 M) produced at least 50 % inhibition (n = 7). The points are fitted
with a sigmoid curve which gives an EC50 of 50 nM. The filled circles were from
slices (n = 5) where the inhibition from 100 M adenosine was < 50 %. The points are
fitted with a sigmoid curve which gives an EC50 of 250 nM. F: Bar chart plotting
inhibition produced by supra-maximal concentrations of CPA (up to 100 M) for
synapses which are sensitive and insensitive to adenosine inhibition.
Fig. 5. A reduction in volley amplitude can only account for the reduction in fEPSP
amplitude at a small minority of synapses where adenosine has little effect. A: Graph
plotting the amplitude of individual PF EPSPs against time. Both adenosine (100 M)
and L-AP4 (50 M) produced a marked reduction in EPSP amplitude. B: Graph
plotting the amplitude of the presynaptic volley against time for the same slice as (A).
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Both adenosine (100 M) and L-AP4 (50 M) produced a small reversible reduction
in volley amplitude. C: Graph plotting mean EPSP amplitude against mean
presynaptic volley amplitude for the same slice in (A and B). To determine the
relationship between presynaptic volley and EPSP amplitude, the stimulus strength
was increased (from minimal stimulation strength) and the mean volley amplitude
was plotted against mean EPSP amplitude for each stimulus. If the effects of
adenosine and L-AP4 on fEPSP amplitude can be accounted for by the reduction in
volley amplitude then fEPSP amplitude plotted against volley amplitude in adenosine
and L-AP4 should fall on the line. The points fall well below the line (filled symbols)
and thus the reduction in fEPSP amplitude cannot be accounted for by a fall in volley
amplitude and by implication cannot be account for by a reduction in active parallel
fibres. D: Graph plotting the amplitude of individual PF fEPSPs against time.
Adenosine (100 M) had little effect but L-AP4 (50 M) produced a marked
reduction in fEPSP amplitude. E: Graph plotting the amplitude of the presynaptic
volley against time for the same slice as (D). Both adenosine (100 M) and L-AP4
(50 M) produced a small reversible reduction in volley amplitude. F: Graph plotting
mean fEPSP amplitude against mean presynaptic volley amplitude for the same slice
in (D and E). The relationship between volley and EPSP amplitude was constructed
by changing the stimulus strength (as above). The amplitude of fEPSPs plotted
against volley amplitude in adenosine (100 M, filled symbol) falls upon the line and
thus the reduction in fEPSP amplitude produced by adenosine can be accounted for by
a fall in volley amplitude and by implication a reduction in active parallel fibres. In
contrast fEPSP amplitude plotted against volley amplitude in L-AP4 (filled symbol)
falls far below the line. Recordings were made in slices from P9-12 rats.
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Fig. 6. Hypoxia has variable effects on parallel fibre synaptic transmission in slices
from P9-12 rats. A: Graph plotting the normalised amplitude of individual parallel
fibre fEPSPs against time (fEPSPs were normalised by dividing by the mean control
amplitude). Hypoxia (N2/CO2) induced a reduction in fEPSP amplitude (~ 47%)
which is almost completely reversed by blocking A1 receptors with 8 CPT (2 M).
Inset, superimposed averages of 15 fEPSPs in control and in 100 M adenosine from
same experiment as (A, adenosine sensitivity measured before hypoxia was induced).
Adenosine reduced fEPSP amplitude by ~ 80 %. B: Graph plotting the paired pulse
ratio against time for fEPSPs in (A, paired pulse interval 50 ms). Hypoxia markedly
increased the paired pulse ratio which was reversed by 8 CPT. C: Graph plotting the
normalised amplitude of individual parallel fibre fEPSPs against time (fEPSPs were
normalised by dividing by the mean control amplitude). Hypoxia induced a rapid
reduction in EPSP amplitude (71 %) which was only partially and transiently reversed
by blocking A1 receptors with 8 CPT (2 M) but was fully reversed by washing in
oxygenated aCSF. Inset, superimposed averages of 15 fEPSPs in control and in
adenosine (100 M) from same experiment as (C, adenosine sensitivity measured
before hypoxia was induced). Adenosine reduced fEPSP amplitude by ~ 20 %. D:
Graph plotting the paired pulse ratio against time for fEPSPs in (C, paired pulse ratio
50 ms). Hypoxia markedly increased the paired pulse ratio which was only partially
and transiently reduced by blocking A1 receptors with 8 CPT (2 M) but was fully
reversed by reoxygenation.
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